STK11 and pancreatic neoplasm: Familial pancreatic cancer accounts for 5–10% of cases; germline mutations in BRCA1/2, CDKN2A, PALB2, STK11/LKB1, TP53 and mismatch-repair genes confer markedly elevated lifetime risks.